Search research articles
Contact Us
Filters
Showing results (271-280 of 297) with videos related to
Page
of 30
Sort By:
Open Forum Infectious Diseases
|
April 21, 2025
SARS-CoV-2 Immune Complex-Mediated Neutrophil Activation
Kiana C Allen, Seth Warner, Heather L Teague, et al.
The New England Journal of Medicine
|
May 18, 2026
Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
Steven D Nathan, Peter Smith, Chunqin Deng, et al.
Pulmonary Circulation
|
October 16, 2023
Pulmonary hemodynamics and transplant-free survival in sarcoidosis-associated pulmonary hypertension: Results from an international registry
Shameek K Gayen, Robert P Baughman, Steven D Nathan, et al.
The Lancet. Respiratory Medicine
|
February 23, 2025
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients
Franck F Rahaghi, Marc Humbert, Marius M Hoeper, et al.
Journal of Intensive Care Medicine
|
September 13, 2024
Plasma Adsorption with the MTx.100 Column in Critically Ill COVID-19 Patients: A Prospective Study and Propensity Score Analysis
Christopher Choi, Nicole De Simone, Christopher B Webb, et al.
Respiratory Medicine
|
June 3, 2018
Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry
Robert P Baughman, Oksana A Shlobin, Athol U Wells, et al.
Plos One
|
March 12, 2020
Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs
Mingjun Zhang, Michael Haughey, Nai-Yu Wang, et al.
Thorax
|
March 13, 2016
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
Steven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Science Advances
|
January 4, 2023
Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19
Gustaf Wigerblad, Seth A Warner, Marcos J Ramos-Benitez, et al.
Annals of Internal Medicine
|
May 8, 2013
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial
Ganesh Raghu, Juergen Behr, Kevin K Brown, et al.
Page
of 30
Search research articles
Search
Showing results (271-280 of 297) with videos related to
Sort By:
Page
of 30
Open Forum Infectious Diseases
|
April 21, 2025
SARS-CoV-2 Immune Complex-Mediated Neutrophil Activation
Kiana C Allen, Seth Warner, Heather L Teague, et al.
The New England Journal of Medicine
|
May 18, 2026
Phase 3 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
Steven D Nathan, Peter Smith, Chunqin Deng, et al.
Pulmonary Circulation
|
October 16, 2023
Pulmonary hemodynamics and transplant-free survival in sarcoidosis-associated pulmonary hypertension: Results from an international registry
Shameek K Gayen, Robert P Baughman, Steven D Nathan, et al.
The Lancet. Respiratory Medicine
|
February 23, 2025
Future treatment paradigms in pulmonary arterial hypertension: a personal view from physicians, health authorities, and patients
Franck F Rahaghi, Marc Humbert, Marius M Hoeper, et al.
Journal of Intensive Care Medicine
|
September 13, 2024
Plasma Adsorption with the MTx.100 Column in Critically Ill COVID-19 Patients: A Prospective Study and Propensity Score Analysis
Christopher Choi, Nicole De Simone, Christopher B Webb, et al.
Respiratory Medicine
|
June 3, 2018
Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry
Robert P Baughman, Oksana A Shlobin, Athol U Wells, et al.
Plos One
|
March 12, 2020
Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs
Mingjun Zhang, Michael Haughey, Nai-Yu Wang, et al.
Thorax
|
March 13, 2016
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
Steven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Science Advances
|
January 4, 2023
Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19
Gustaf Wigerblad, Seth A Warner, Marcos J Ramos-Benitez, et al.
Annals of Internal Medicine
|
May 8, 2013
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial
Ganesh Raghu, Juergen Behr, Kevin K Brown, et al.
Page
of 30